Immunotherapy Now Standard for Some Patients With CRC
John Leighton, MD, shares his thoughts on the headline Immunotherapy Now Standard for Some Patients With Colorectal Cancer
Author: obr
Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Advancements in the treatment of colorectal cancer
Atrayee Basu Mallick, MD, shares the advances in the treatment of colorectal cancer
Author: obr
Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts
The VALENTINO study
Howard Hochster, MD, weighs in on the VALENTINO study regarding the effectiveness of maintenance 5FU/LV following FOLFOX + panitumumab induction in metastatic colorectal cancer patients
Author: obr
Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts
How tumor-sidedness impacts CRC treatment algorithms
Atrayee Basu Mallick, MD, talks about how tumor-sidedness impacts her colorectal cancer (CRC) treatment algorithms at ASCO 2018.
Author: obr
Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts
The outcomes of ECOG-7208 in 2nd line mCRC
Howard Hochster, MD, explains the outcomes of the ECOG-7208 study in 2nd line metastatic colorectal cancer (mCRC) patients at ASCO 2018.
Author: obr
Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts
How nivolumab is incorporated into mCRC treatment algorithms
Atrayee Basu Mallick, MD, shares how nivolumab is being incorporated into metastatic colorectal cancer (mCRC) treatment algorithms at ASCO 2018.
Author: obr
Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts
How tumor sidedness impacts CRC treatment algorithms
John Leighton, MD, explains whether tumor sidedness impacts colorectal cancer treatment algorithms at ASCO 2018.
Author: obr
Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts
The outcomes of the Checkmate 142 study in mCRC
Atrayee Basu Mallick, MD, shares her thoughts on the outcomes of the Checkmate 142 study looking ipilimumab and nivolumab in metastatic colorectal cancer (mCRC) patients at ASCO 2018.
Author: obr
Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts
The outcomes of Checkmate 142 in mCRC
John Leighton, MD, shares the outcomes of the Checkmate 142 study examining ipilimumab and nivolumab in metastatic colorectal cancer (mCRC) patients at ASCO 2018.
Author: obr
Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts
The addition of vemurafenib to the NCCN guidelines for mCRC
Atrayee Basu Mallick, MD, talks about the patient type and setting where vemurafenib has been added to the NCCN guidelines for metastatic colorectal cancer (mCRC) patients at ASCO 2018
Author: obr
Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts
How nivolumab is incorporated into mCRC treatment algorithms
Atrayee Basu Mallick, MD, shares how how nivolumab is being incorporated into metastatic colorectal cancer (mCRC) treatment algorithms at ASCO 2018.
Author: obr
Added: 07/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy in colorectal cancer
Atrayee Basu Mallick, MD, shares her thoughts on immunotherapy in colorectal cancer at ASCO 2018.
Author: obr
Added: 07/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 19, 2018 Category: Cancer & Oncology Source Type: podcasts
How tumor-sidedness impacts colorectal cancer treatment algorithms
Al Benson III, MD, FACP, explains how tumor-sidedness impacts colorectal cancer treatment algorithms at ASCO 2018.
Author: obr
Added: 07/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Role of I-O and immunotherapy combinations when treating CRC
Al Benson III, MD, FACP, explains the role of I-O and immunotherapy when treating colorectal cancer at ASCO 2018
Author: obr
Added: 07/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2018 Category: Cancer & Oncology Source Type: podcasts
What molecular markers are most important to test for when treating CRC patients
Dr. Benson, Professor of Medicine, Northwestern University, shares which molecular markers are most important when treating colorectal cancer patients.
Author: obr
Added: 07/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2018 Category: Cancer & Oncology Source Type: podcasts
